Biobanking for OVCA (Ovarian Cancer) - Clinical Trial

¿Cuál es el Propósito de este estudio?

We are doing this study to collect data, liquid biopsies (blood and urine), and cancer specimens from women with primary epithelial ovarian, peritoneal, or tubal cancer. We are using this information and these samples to create a biobank that might identify future therapeutic targets and help develop new therapies for these types of cancer.

¿Cuál es la Condición que se está estudiando?

Stage III or IV Primary Epithelial Ovarian, Peritoneal, or Tubal Cancer

¿Quién puede participar en el Estudio?

Adults ages 18+ who:

  • Have a diagnosis of primary epithelial ovarian, peritoneal, or tubal cancer
  • Have Stage III or IV disease, or recurrent disease
  • Are eligible for treatment with chemotherapy or have already received chemotherapy

For more information about this study, please contact the study team at sarah.linhart@duke.edu.

Grupo etario
Adultos

¿Qué Implica?

If you choose to join this study, we will ask your permission to let us save some samples that you've already provided so we can use them for research. We will also schedule you to have a blood draw approximately every 3 months.

Detalles del Estudio

Título Completo
Biobanking for Longitudinal Monitoring of Ovarian Cancer
Investigador Principal
Especialista en oncología ginecológica
Número de Protocolo
IRB: PRO00109365
Estado de inscripción
Abierto para inscripción